NI
Digital Experience Engineer responsible for developing and optimising digital platforms for a medical device company. Enhancing customer engagement and ensuring compliance with data protection laws.
NI
NIOX®
Currently Hiring
About the company
NIOX Group plc is a company that specialises in the development, manufacture, and distribution of medical devices for the diagnosis and monitoring of asthma.
Their flagship product, NIOX VERO®, is a non-invasive medical device that measures fractional exhaled nitric oxide (FeNO) levels in patients with asthma.
NIOX VERO® provides accurate and reliable results, allowing healthcare
professionals to make informed decisions about the diagnosis and management of asthma.
It is easy to use, and can be used in a variety of settings, including clinics, hospitals, and primary care settings.
The NIOX Group plc is committed to improving the lives of people with asthma and is dedicated to innovation and excellence in its products and services.
NIOX® is also committed to offering additional training and support for healthcare professionals.
Overall, NIOX Group plc is the global leader in FeNO testing, with a strong
reputation for innovation and excellence in the development of medical devices for the diagnosis and management of asthma.
With NIOX VERO®, healthcare professionals have a reliable and non-invasive tool to help them better diagnose and manage asthma.
References:
1.
Alving K et al.
Validation of a new portable exhaled nitric oxide analyzer, NIOX VERO®: randomized studies in asthma.
Pulm Ther.
2017;3:207-218.
2.
Gao J et al.
Association between fractional exhaled nitric oxide, sputum induction and peripheral blood eosinophil in uncontrolled asthma.
Allergy, Asthma & Clinical Immunology.
2018;1
3.
Busse WW et al.
Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis.
Lancet Respir Med.
2021;9(10):1165-1173.
4.
Menzies-Gow A et al.
Clinical utility of fractional exhaled nitric oxide in severe asthma management.
Eur Respir J.
2020;55(3):1901633.
5.
NIOX®.
Data on File; MKT-DOF-007.
Open jobs
Browse and apply for open jobs at NIOX®.
5 jobs found
Sell NIOX point - of - care asthma diagnostic products to clinical customers across assigned US territory. Drive revenue growth, manage relationships, and coordinate with regional sales and marketing teams.
Field Clinical Sales Representative driving NIOX point - of - care asthma device sales across a selected U.S. territory, reporting to the Regional Sales Development Manager.
NI
Finance Administrator for NIOX handling AP, AR, purchase orders, Concur expense management, vendor and office administration.
NI
NIOX®Staff Accountant
Staff Accountant overseeing accounts receivable, accounts payable, inventory and finance administration for NIOX medical device company, supporting Controller and supervising Finance Administrator.